{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:53:49Z","timestamp":1791219229559,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association between diagnostic delay and major organ involvement (MOI) in Beh\u00e7et\u2019s syndrome (BS), accounting for time at risk and heterogeneity in disease trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective monocentric cohort study including 173 patients with BS fulfilling ISG and\/or ICBD criteria and with at least 5\u2009years of follow-up. Patients were classified according to the presence or absence of MOI (ocular, neurological, gastrointestinal or vascular involvement). Diagnostic delay was defined as the time from symptom onset to diagnosis. Logistic regression and sensitivity models assessed the association between diagnostic delay and cumulative MOI, accounting for age at onset, sex and disease duration. Time-to-event analyses were performed among patients without MOI at disease onset to evaluate incident MOI during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 173 patients, 101 (58.4%) had at least one cumulative MOI. Timing of first MOI was available for 100 patients: 67 had MOI already present at disease onset, whereas 33 developed incident MOI during follow-up. Diagnostic delay was longer in patients with cumulative MOI than in those without MOI. In the initial logistic regression model adjusted for age at onset and sex, diagnostic delay was associated with cumulative MOI; however, this association was attenuated after accounting for disease duration. Time-to-event analysis among patients without MOI at disease onset did not show a statistically significant association between diagnostic delay and incident MOI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Diagnostic delay was associated with cumulative MOI in BS; however, this association was attenuated after accounting for disease duration and time at risk. The findings support the existence of heterogeneous disease trajectories, including early severe disease, incident MOI during follow-up and absence of MOI over the observed period. These results should be interpreted as hypothesis-generating and require confirmation in prospective longitudinal studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag528","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:35:05Z","timestamp":1790076905000},"source":"Crossref","is-referenced-by-count":0,"title":["Timing matters: diagnostic delay and major organ involvement in Beh\u00e7et\u2019s syndrome"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-9611","authenticated-orcid":false,"given":"Rosaria","family":"Talarico","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Di Cianni","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa , Pisa,","place":["Italy"]},{"name":"Department of Medical Biotechnologies, University of Siena , Siena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Sulis","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Marinello","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Manca","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , Pisa,","place":["Italy"]},{"name":"Department of Mathematics, University of Pisa , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2026100511570990100_keag528-B1","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","article-title":"Beh\u00e7et\u2019s syndrome","volume":"403","author":"Emmi","year":"2024","journal-title":"Lancet"},{"key":"2026100511570990100_keag528-B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11926-026-01218-y","article-title":"Beh\u00e7et\u2019s syndrome","volume":"28","author":"Yazici","year":"2026","journal-title":"Curr Rheumatol Rep"},{"key":"2026100511570990100_keag528-B3","doi-asserted-by":"publisher","first-page":"110549","DOI":"10.1016\/j.clim.2025.110549","article-title":"Etiopathogenesis of Beh\u00e7et\u2019s disease: a systematic literature review","volume":"279","author":"Belfeki","year":"2025","journal-title":"Clin Immunol"},{"key":"2026100511570990100_keag528-B4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/sjopt.sjopt_416_25","article-title":"Immunogenetics of Beh\u00e7et\u2019s disease: is there a link to recent phenotypic changes?","volume":"39","author":"Kirino","year":"2025","journal-title":"Saudi J Ophthalmol"},{"key":"2026100511570990100_keag528-B5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.55563\/clinexprheumatol\/4thkqz","article-title":"The relationship between NETosis findings and disease activity in Beh\u00e7et\u2019s disease: an exploratory study","volume":"43","author":"Bektas","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"2026100511570990100_keag528-B6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.55563\/clinexprheumatol\/8xuim0","article-title":"Beh\u00e7et\u2019s syndrome: one year in review 2025","volume":"43","author":"Hatemi","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"2026100511570990100_keag528-B7","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3389\/fimmu.2019.02830","article-title":"Treating the different phenotypes of Beh\u00e7et\u2019s syndrome","volume":"10","author":"Bettiol","year":"2019","journal-title":"Front Immunol"},{"key":"2026100511570990100_keag528-B8","doi-asserted-by":"publisher","first-page":"1605714","DOI":"10.3389\/fimmu.2025.1605714","article-title":"Assessing disease phenotypes in Beh\u00e7et\u2019s syndrome: insights from a multiple correspondence analysis","volume":"16","author":"Talarico","year":"2025","journal-title":"Front Immunol"},{"key":"2026100511570990100_keag528-B9","doi-asserted-by":"publisher","first-page":"152744","DOI":"10.1016\/j.semarthrit.2025.152744","article-title":"Variability in phenotype clusters of Beh\u00e7et\u2019s syndrome: a systematic review","volume":"73","author":"Macit","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2026100511570990100_keag528-B10","doi-asserted-by":"publisher","first-page":"keaf613","DOI":"10.1093\/rheumatology\/keaf613","article-title":"Risk of major organ involvement in Beh\u00e7et\u2019s patients with mucocutaneous onset: data from the AIDA Network Registry","volume":"65","author":"Vitale","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"2026100511570990100_keag528-B11","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.ard.2026.02.009","article-title":"EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome: 2025 update","volume":"85","author":"Hatemi","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"2026100511570990100_keag528-B12","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/rheumatology\/keae416","article-title":"De novo manifestations during adalimumab treatment in Beh\u00e7et\u2019s syndrome","volume":"64","author":"Esatoglu","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026100511570990100_keag528-B13","doi-asserted-by":"publisher","first-page":"105819","DOI":"10.1016\/j.jbspin.2024.105819","article-title":"Influence of gender on Beh\u00e7et\u2019s disease phenotype and irreversible organ damage: data from the International AIDA Network Beh\u00e7et\u2019s Disease Registry","volume":"92","author":"Sota","year":"2025","journal-title":"Joint Bone Spine"},{"key":"2026100511570990100_keag528-B14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.revmed.2024.06.007","article-title":"Neuro-Beh\u00e7et\u2019s disease: a review","volume":"45","author":"Belfeki","year":"2024","journal-title":"Rev Med Interne"},{"key":"2026100511570990100_keag528-B15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40123-025-01258-0","article-title":"The risk of developing ocular involvement among Beh\u00e7et\u2019s disease patients presenting with mucocutaneous involvement at disease onset: data from the International AIDA Network Beh\u00e7et\u2019s Disease Registry","volume":"15","author":"Vitale","year":"2026","journal-title":"Ophthalmol Ther"},{"key":"2026100511570990100_keag528-B16","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226113","article-title":"Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Beh\u00e7et\u2019s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial","author":"Talarico","journal-title":"Ann Rheum Dis"},{"key":"2026100511570990100_keag528-B17","doi-asserted-by":"publisher","first-page":"1726690","DOI":"10.3389\/fimmu.2025.1726690","article-title":"A 20-year real-world study on drug survival and predictive factors for infliximab discontinuation in Beh\u00e7et\u2019s syndrome","volume":"16","author":"Talarico","year":"2025","journal-title":"Front Immunol"},{"key":"2026100511570990100_keag528-B18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10067-015-2906-1","article-title":"Development of de novo major involvement during follow-up in Beh\u00e7et\u2019s syndrome","volume":"35","author":"Talarico","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2026100511570990100_keag528-B19","doi-asserted-by":"publisher","first-page":"109272","DOI":"10.1016\/j.clim.2023.109272","article-title":"Difficult-to-treat Beh\u00e7et syndrome: a therapeutic approach","volume":"249","author":"Yazici","year":"2023","journal-title":"Clin Immunol"},{"key":"2026100511570990100_keag528-B20","doi-asserted-by":"publisher","first-page":"109186","DOI":"10.1016\/j.clim.2022.109186","article-title":"Treat to target in Behcet\u2019s disease: should we follow the paradigm of other systemic rheumatic diseases?","volume":"246","author":"Fragoulis","year":"2023","journal-title":"Clin Immunol"},{"key":"2026100511570990100_keag528-B21","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.coi.2025.102597","article-title":"Can we cure Beh\u00e7et syndrome?","volume":"95","author":"Yazici","year":"2025","journal-title":"Curr Opin Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag528\/71326815\/keag528.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/10\/keag528\/71326815\/keag528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/10\/keag528\/71326815\/keag528.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:57:14Z","timestamp":1791215834000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag528\/8830119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag528","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,22]]},"article-number":"keag528"}}